APYX Apyx Medical

APYX MEDICAL CORPORATION Company News: Berger Montague Investigates Securities Fraud Allegations Against Apyx Medical Corp. (NASDAQ: APYX); Lead Plaintiff Deadline is August 5, 2022

PHILADELPHIA, June 30, 2022 /PRNewswire/ -- Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) between May 12, 2021 and March

02:41

Press Release: Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022 CLEARWATER, Fla.--(BUSINESS WIRE)--June 30, 2022-- Apyx Medical Corporation (NASDAQ:APYX)

06-30 19:31

Apyx Medical (APYX) Stock: Why it Increased 3.49%

The stock price of Apyx Medical Corp (NASDAQ: APYX) increased by 3.49% in the previous trading session. This is why. The stock price of Apyx Medical Corp (NASDAQ: APYX) – the manufacturer of Renuvion

06-29 21:15

NS, MNTS and AGRX among pre market gainers

Kezar Life Sciences (KZR) +93% after mid-stage data for lupus nephritis candidate. Agile Therapeutics (AGRX) +46%. Evofem Biosciences (EVFM) +33% collaboration for birth control method. InflaRx (IFR

06-28 20:52

Apyx Medical Announces FDA 510(k) Clearance For Renuvion Dermal In Wrinkle-Reduction Procedures

Apyx Medical Announces FDA 510(k) Clearance For Renuvion Dermal In Wrinkle-Reduction Procedures

06-28 19:40

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Apyx Medical Corporation - APYX

Newsfile 25-Jun-2022 7:22 PMNew York, New York--(Newsfile Corp. - June 25, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation ("Apyx" or the "Company")

06-26 07:25

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX

PRNewswire 8-Jun-2022 9:16 PMNEW YORK, June 8, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX).

06-09 09:24

FDA Roundup: June 3, 2022

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Thursday, the FDA updated our March 2022 safety communication to inform consumers and health care providers about a new handpiece that has been FDA cleared for use with the Renuvion/J-Plasma device system by Apyx Medical. The Renuvion Dermal Handpiece can be used for the treatment of moderate to severe wrinkles and rhytides in patients with Fitzpatrick Skin Types I, II, or III. The Renuvion/J-Plasma device system has not been cleared to be used for any other aesthetic skin procedures. Wednesday, the FDA announced an open period for applications to support the development of eviden...

06-04 05:21

Do the Stock Experienced Heavy Trading? Apyx Medical Corporation (NASDAQ:APYX) encountered the change of 11.57%

Shares of Apyx Medical Corporation (NASDAQ:APYX) reached at $6.27 price level during last trade its distance from 20 days simple moving average was 72.64%, and its distance from 50 days simple movin

05-30 08:55

Hair-raising Facts to Know: Apyx Medical Corporation (NASDAQ:APYX 51.89%), The Gap, Inc. (NYSE:GPS 4.41%)

Apyx Medical Corporation (NASDAQ:APYX) with the stream of 51.89% also noticed, India The Gap, Inc. (NYSE:GPS) encountered a rapid change of 4.41% in the last hour of Thursday's trading session. Apyx

05-27 07:51